DE3382387D1 - Loesungen von aminosaeuren zur parenteralen naehrung sowie dosierverfahren und verwendung. - Google Patents

Loesungen von aminosaeuren zur parenteralen naehrung sowie dosierverfahren und verwendung.

Info

Publication number
DE3382387D1
DE3382387D1 DE8383902154T DE3382387T DE3382387D1 DE 3382387 D1 DE3382387 D1 DE 3382387D1 DE 8383902154 T DE8383902154 T DE 8383902154T DE 3382387 T DE3382387 T DE 3382387T DE 3382387 D1 DE3382387 D1 DE 3382387D1
Authority
DE
Germany
Prior art keywords
amino acid
acid solutions
parenteral nutrition
dosing method
dosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8383902154T
Other languages
English (en)
Inventor
Ralph B Dell
Robert W Winters
William C Heird
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27008332&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3382387(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Application granted granted Critical
Publication of DE3382387D1 publication Critical patent/DE3382387D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8383902154T 1982-05-17 1983-05-16 Loesungen von aminosaeuren zur parenteralen naehrung sowie dosierverfahren und verwendung. Expired - Lifetime DE3382387D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37874382A 1982-05-17 1982-05-17
US06/487,409 US4491589A (en) 1982-05-17 1983-04-29 Amino acid solutions for parenteral nutrition and methods of formulation and use
PCT/US1983/000759 WO1983003969A1 (en) 1982-05-17 1983-05-16 Amino acid solutions for parenteral nutrition and methods of formulation and use

Publications (1)

Publication Number Publication Date
DE3382387D1 true DE3382387D1 (de) 1991-10-02

Family

ID=27008332

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383902154T Expired - Lifetime DE3382387D1 (de) 1982-05-17 1983-05-16 Loesungen von aminosaeuren zur parenteralen naehrung sowie dosierverfahren und verwendung.

Country Status (7)

Country Link
US (1) US4491589A (de)
EP (1) EP0109439B1 (de)
JP (1) JPH0811728B2 (de)
CA (1) CA1212902A (de)
DE (1) DE3382387D1 (de)
IT (1) IT1173715B (de)
WO (1) WO1983003969A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123413A (ja) * 1983-12-05 1985-07-02 Ajinomoto Co Inc 新アミノ酸輸液
FR2556594B1 (fr) * 1983-12-20 1988-09-09 Synthelabo Solutions d'acides amines
US5719119A (en) * 1985-12-18 1998-02-17 British Technology Group, Ltd. Parenteral nutrition therapy with amino acids
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5189025A (en) * 1988-12-09 1993-02-23 Board Of Regenets, The University Of Texas System Methods for the treatment of malignant disease in patients using citrulline containing amino acid solutions
US6017957A (en) * 1989-08-08 2000-01-25 The United States Of America As Represented By The Department Of Health And Human Services Partial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agents
DE3936319C3 (de) * 1989-11-01 1997-05-07 Bartz Volker Phosphatbinder zur oralen Verabreichung
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
US5206220A (en) * 1990-04-23 1993-04-27 Research Corporation Technologies, Inc. Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
US5646187A (en) * 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
AU682894B2 (en) * 1993-10-28 1997-10-23 Institut National De La Recherche Agronomique Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US20040022827A1 (en) * 1997-09-30 2004-02-05 Chugai Seiyaku Kabusiki Kaisha Remedy for hepatopathy
US6841158B1 (en) * 1998-09-22 2005-01-11 Boehringer Ingelheim International Gmbh Recombinant celo virus and celo virus DNA
DE69904257T2 (de) * 1999-01-20 2003-04-17 Nutricia Nv Säuglingsnährpräparat
ATE334667T1 (de) * 2000-01-18 2006-08-15 Ajinomoto Kk Alanin- und glycin-haltige arzneien gegen hepatitis
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US6620850B2 (en) 2001-09-19 2003-09-16 University Of Florida Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
EP2382874A1 (de) 2003-06-23 2011-11-02 Nestec S.A. Aminosäureergänzung für ein gesundes mikrobiotisches Ökosystem
AU2006250072A1 (en) * 2005-05-26 2006-11-30 Pediatrix Medical Group, Inc. Nutrition formulations and methods of providing nutrition formulations
JP2008542255A (ja) * 2005-05-27 2008-11-27 ファイザー・プロダクツ・インク 肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
NZ565765A (en) * 2005-08-02 2010-01-29 Baxter Int Multiple chamber container
RU2414897C2 (ru) * 2005-11-30 2011-03-27 Нестек С.А. Способы лечения потери мышечной массы
CA2843880A1 (en) * 2008-07-07 2010-01-14 Pentec Health, Inc. Nutritive compositions and methods of using same
WO2011021926A1 (en) 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
JP5774603B2 (ja) * 2010-01-04 2015-09-09 ペンテック ヘルス， インコーポレイテッド 栄養組成物およびその使用方法
AU2012340563B2 (en) 2011-11-21 2017-01-19 The Institute For Ethnomedicine L-serine compositions, methods and uses for treating neurodegenerative diseases and disorders
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2411897A (en) * 1943-01-02 1946-12-03 Sterling Drug Inc Pharmaceutical solution
US2662046A (en) * 1948-06-19 1953-12-08 Merck & Co Inc Parenteral amino acid solution
GB931016A (en) * 1960-12-22 1963-07-10 Distillers Co Yeast Ltd Amino acids concentrate and intravenous preparations thereof
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
JPS5536457A (en) * 1978-09-08 1980-03-14 Ajinomoto Co Inc Amino acid infusion
JPS568312A (en) * 1979-07-03 1981-01-28 Otsuka Pharmaceut Factory Inc Amino acid pharmaceutical preparation
DE2946563A1 (de) * 1979-11-17 1981-05-21 B. Braun Melsungen Ag, 3508 Melsungen Aminosaeureloesung zur parenteralen infusion
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure

Also Published As

Publication number Publication date
EP0109439A1 (de) 1984-05-30
IT8348303A0 (it) 1983-05-16
US4491589A (en) 1985-01-01
EP0109439B1 (de) 1991-08-28
IT1173715B (it) 1987-06-24
JPH0811728B2 (ja) 1996-02-07
WO1983003969A1 (en) 1983-11-24
JPS59500966A (ja) 1984-05-31
EP0109439A4 (de) 1986-06-05
CA1212902A (en) 1986-10-21

Similar Documents

Publication Publication Date Title
DE3382387D1 (de) Loesungen von aminosaeuren zur parenteralen naehrung sowie dosierverfahren und verwendung.
DE3177130D1 (de) Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
DE3585147D1 (de) Verfahren zur reinigung von proteinen.
DE3582061D1 (de) Verfahren und vorrichtung zur ueberwachung von redoxreaktionen.
DE3581765D1 (de) Elektrochemisches verfahren und vorrichtung zur herstellung.
DE3577872D1 (de) Fluessigkristallzusammensetzung, verfahren und vorrichtung.
DE3579129D1 (de) Zusammensetzung und verfahren zur behandlung von kunststoffen mit alkalipermanganat-loesungen.
DE3484834D1 (de) Verfahren zur herstellung von polyamidiminen und deren verwendung.
DE3677520D1 (de) Vorrichtung zur behandlung von behaeltern.
DE3578468D1 (de) Tragbares, persoenliches terminalgeraet und system zur behandlung von transaktionen mit einem derartigen geraet.
DE3574475D1 (de) Dextranhexonsaeureverbindung, komplex mit ferrihydroxyd und verfahren zu deren herstellung.
DE3774897D1 (de) Behandelte sojabohnen mit reduziertem phosphor- und kaliumgehalt, verfahren zur zubereitung derselben und damit erhaltene sojabohnen-nahrungsmittel.
DE3677740D1 (de) 2-iod-perfluor-2-methylalkane, verfahren zu deren herstellung und deren verwendung.
DE3688410D1 (de) Verfahren, system und schaltung zur anpassung der verzoegerungszeit.
DE3684511D1 (de) Verfahren zur herstellung von l-threonin und l-isoleucin.
DE3680352D1 (de) Leitfaehigkeitsmodulations-halbleiteranordnung und verfahren zu ihrer herstellung.
DE3678719D1 (de) Verfahren zur herstellung von einzeln dosierten darreichungsformen sowie die danach erhaeltlichen darreichungsformen.
DE3574523D1 (de) Verfahren zur dotierung von halbleitermaterial.
DE3671231D1 (de) Cysteinreiche, gamma-glutaminsaeure-einheiten aufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
DE3578161D1 (de) Verfahren zur behandlung von fluessigkeiten.
DE3671246D1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion.
DE3683628D1 (de) Verfahren zur flaechenbehandlung.
DE3688395D1 (de) Verfahren zur flaechenbehandlung.
DE3581590D1 (de) Statistische halogenierte aethylencopolymere und verfahren zur herstellung davon.
DE3869633D1 (de) Verfahren zur herstellung von n,n-(dibenzohexatrienylen)harnstoffen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT